Peptide research profile
GHK-Cu
Also known as copper peptide · copper tripeptide-1 · ghkcu · glycyl-L-histidyl-L-lysine copper
Fibroblast studies support collagen-related biological activity, but this cannot establish clinical anti-aging, hair-growth, wound-healing, or systemic outcomes. Finished topical cosmetics and injectable GHK-Cu are different evidence questions.
Very low evidenceNot FDA approved
- Evidence maturity
- Early signal
- Regulatory status
- Not FDA approved
- Recorded outcomes
- 3
- Indexed sources
- 2
- Side-effect records
- 143Named most often: Dizziness · Injection site reaction · Fatigue
Educational. Not medical advice.
Summary
A naturally occurring copper-binding tripeptide with laboratory evidence that does not establish systemic or injectable benefit.
What is GHK-Cu being studied for?
Collagen and extracellular-matrix research
How is it thought to work?
Binds copper and influences collagen synthesis and extracellular-matrix signaling in laboratory models.
Recorded outcomes
143 side-effect records on GHK-Cu
Free account3 graded outcomes and 2 sources for GHK-Cu.
Outcome table and every source open with a free account. No card.
Update history
Updated
- Editorial review of the profile and its sources.
- Record last updated in the Senzu database.
- Profile first published.